A next generation of stem cell applications

Our Mission

American Regenerative Medicine Corporation aims to provide clinicians with a comprehensive set of off-the-shelf regenerative medicine products for significant unmet clinical needs.

Innovation in Stem Cell Technologies

ARMC's stem cell kit manufacturing cycle scales easily to any size market..Read More

What We Do

American Regenerative Medicine Corporation aims to provide clinicians with a comprehensive set of off-the-shelf regenerative medicine products for significant unmet clinical needs, based on the successful results of Dr. Minjie Gu's adult stem cell therapy clinical trials in China.

Read More »

Core Technologies

The Company's proprietary cell-based core technologies include methods for producing highly purified, immunoselected Mesenchymal Precursor Cells (MPCs), culture-expanded Mesenchymal Stem Cells (MSCs), Dental Pulp Stem Cells (DPSCs), Adipose Stem Cells (ASCs), expanded Hematopoietic Stem Cells (HSCs) and combination dendritic (DCs)/cytokine-induced killer (CIKs) cells. The Company's protein generation technologies are based on factors derived from Dr. Gu's proprietary cell-based core technologies.

Read More »

Company Leadership

Dr.Gu is the President and Chief Scientist of the American Regenerative Medicine Corporation, Adviser of Maternal and Child Health Care of China Association and Chief Scientist of the Regenerative Medical Center, 981 Health Science & Technology Group Co., Ltd. She was an Associate Professor of Beijing University of Chinese Medicine and deputy director of the clinical dept. of Dongzhimen Hospital. 

Read More »